The QualityStocks Daily Wednesday, April 11th, 2018

Today's Top 3 Investment Newsletters

MarketBeat (LEDS) +39.07%

StockMarketWatch (PVG) +19.34%

Daily Trade Alert (AVAV) +17.06%

The QualityStocks Daily Stock List

Kerr Mines, Inc. (KERMF)

InvestorsHub, StockWatch, Barchart, The Street, Journal Transcript, MarketWatch, Stockhouse, Streetwise Reports, Financial Trends, and Wall Street Analyzer reported on Kerr Mines, Inc. (KERMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Kerr Mines, Inc. is a North American gold development and exploration company based in Toronto, Ontario. The Company is now advancing the fully permitted past-producing Copperstone Mine project. Copperstone is a high-grade gold project. It is situated along the Walker Lane mineral belt in Arizona. Kerr Mines lists on the OTC Markets Group’s OTCQB.

The Company acquired the Copperstone gold mine in 2014. The mine is fully permitted. It has substantial mining infrastructure, mineral resources, and processing infrastructure in place. The Copperstone Mine produced almost one-half million ounces of gold between 1987 and 1993 through open pit mining.

Regarding existing infrastructure, the Copperstone Mine project has underground mine development in place, access, and utilities. In addition, it has a 450 tons per day processing plant; power and water distribution systems; and roads and access to surface exploration sites. The Copperstone Mine also has a tailings storage facility with capacity for existing resource and surface buildings including an assay laboratory.

The Copperstone Mine project shows considerable upside exploration potential within a 12,000 acre land package. The focus for Kerr Mines is to maximize Copperstone’s potential through defining and expanding current resources. The Company’s focus is to also strengthen the mine’s economics leading to a production decision.

Recently, Kerr Mines announced that, following the successful 2017 Phase I exploration program in the Copperstone and Footwall zones, it is continuing with a 15,000 meter 2018 Phase II program with the goal of expanding the mineral resource. The 2017 Phase I program confirmed significant gold mineralization. The program increased the potential in expanding the resource at Kerr’s Copperstone Project in Arizona. The 2018 Phase II Program plans for up to 15,000 meters of infill and extensional drilling mainly in the Copperstone Zone.

The goals of the 2018 Phase II Exploration Program are to increase the mineral resource and improve the mineral classification in the Copperstone Zone. Goals also include increasing the mineral resource and improving the mineral classification in the parallel Footwall Zone located within 150 meters of the Copperstone Zone. Furthermore, goals include better defining mining stopes in the D and C zones of the Copperstone Zone.

Yesterday, Kerr Mines announced the results of the independent Pre-Feasibility study (PFS Study) and resource update prepared by Hard Rock Consulting, LLC in accordance with National Instrument 43-101 (NI 43-101) for its past producing Copperstone Mine in Arizona. Kerr Mines confirmed updated gold resources and positive economics at its Copperstone Mine.

Mr. Martin Kostuik, President of Kerr Mines, said, “The results of this PFS display the strong near-term production opportunity for the Copperstone Mine and robust returns for our investors. This is just the beginning. The impressive exploration upside displayed by the 2017 Phase I program, the historical production of over 500,000 gold ounces and the potential to generate solid positive cash flows by identifying the first four years of gold production, all point toward the opportunity of many more years, beyond the Study timeframe, of profitable production.

Kerr Mines, Inc. (KERMF), closed Wednesday's trading session at $0.1582, down 8.93%, on 802,883 volume with 259 trades. The average volume for the last 60 days is 59,680 and the stock's 52-week low/high is $0.117/$0.3365.


Nutritional High International, Inc. (SPLIF)

SmallCapVoice, Promotion Stock Secrets, CFN Media Group, and SECFilings News reported on Nutritional High International, Inc. (SPLIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nutritional High International, Inc. focuses on developing, manufacturing, and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries. These include edibles and oil extracts for nutritional, medical, and adult recreational use. Nutritional High International works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law. The Company is based in Toronto, Ontario. Nutritional High International lists on the OTC Markets.

Concerning its Hemp-Infused Products segment, it launched the first product in its Active Hemp category under the brand of “Nutritional Traditions”. Also, concerning its Hemp-Infused Products segment, initial distribution will focus on California and Colorado through cannabis-related retail stores: medical marijuana dispensaries, vape lounges and headshops; and Food Supplement retail stores (including vitamin stores, supplement stores, and more).

Regarding its Marijuana-Infused Products segment, the Company concentrates on developing, acquiring, and designing Marijuana-Infused Products (MIPs) and Marijuana Concentrate products and brands. In this segment, it is establishing operations in Colorado and Illinois. It is working to expand into additional U.S. States in support of its strategy to establish some of the first nationally-recognized brands for MIPs.

Nutritional High International entered into an agreement to acquire the technology and IP rights to an inventive product to be referred to as the “Dab Stick”. The Dab Stick is a dispenser for viscous liquid substances. It can carry roughly 1⁄2 gram of cannabis oil extract designed with the retail consumer and adult use user in mind.

Earlier this month, Nutritional High International announced that Weedmaps will be featuring the Company’s FLI brand as one of the leading brands of cannabis oil vapes in the State of Colorado. Weedmaps is the world’s first marijuana technology and media brand. It is also the most comprehensive marijuana directory.

At present, FLI-branded products are being manufactured and distributed in Colorado by Palo Verde LLC. Palo Verde is the tenant at the Company’s Pueblo, Colorado facility. Palo Verde has been manufacturing FLI-branded vape cartridges, syringes and chocolates. Moreover, it has recently launched "Dab" products that contain 1,000 mg jars of cannabis oil distillate. FLI "Dab" products are targeted towards the cannabis concentrate "aficionado" who prefers to consume oil by "dabbing."

Last week, Nutritional High International announced that it started the sale of FLI vape cartridges in California. These products are now on the shelves of a number of medical dispensaries in the State. The Company engaged a licensed manufacturer (CA Manufacturer) to produce FLI-branded vape cartridges to Nutritional High’s specifications.  

Nutritional High International, Inc. (SPLIF), closed Wednesday's trading session at $0.29, up 3.72%, on 55,660 volume with 33 trades. The average volume for the last 60 days is 199,870 and the stock's 52-week low/high is $0.055/$0.9419.


Asia Equity Exchange Group, Inc. (AEEX)

InvestorsHub, OTC Markets, and MarketWatch reported on Asia Equity Exchange Group, Inc. (AEEX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Asia Equity Exchange Group, Inc. is working to establish and build an equity information service platform designed to provide equity investment financing information to all enterprises in the nations and regions of Asia. The Company, with its website, invested and operated by Asian Equity Exchange Group Co., Ltd., is an intercontinental equity exchange and a service platform for companies in Asia to release equity investment and financing information.

Asia Equity Exchange Group has offices in Kowloon Bay, Hong Kong; Shenzhen, China; and New York, New York. The Company successfully entered into the U.S. capital markets in November of 2013.

Fundamentally, Asia Equity Exchange Group integrates global capital and works with providers’ of a wide assortment of services. It provides growing and innovative companies with diversified and professional services, and worldwide professional investors with quality, open, and varied investment opportunities. The Company serves as a significant part and an important link of the multi-layered capital markets in Asia. Asia Equity Exchange Group enables companies to obtain the resources to successfully launch their IPO (Initial Public Offering).

The operating structure of the Company is: Asia Equity Exchange Group, Inc. 100 percent shareholding Asian Equity Exchange Group Co. Ltd. 100 percent shareholding AEEX (HK) International Financial Services Limited 100 percent shareholding Asian & American Consultant (Shenzhen) Co. Ltd.

Asia Equity Exchange Group helps companies develop in a sustainable manner. In addition, the Company introduces high-value investment markets to professional institutional and individual investors. Furthermore, it aims to create an innovative and authoritative intercontinental equity information platform that effectively complements business functions, service means and financing channels with OTC markets in different nations and regions.

Moreover, Asia Equity Exchange Group is working to build a system of intercontinental cooperation to provide listed enterprises with equity financing means via domestic and out of the country channels, and to provide nurturing, pre-listing tutoring, and incubating, as well as supporting services for their listing on overseas capital markets by shifting boards. The Company can provide the referral of third-party professional service providers, for example, Legal Counselling, PCAOB auditors and other related agencies, required for international listing to members.

Asia Equity Exchange Group, Inc. (AEEX), closed Wednesday's trading session at $5.23, down 0.19%, on 100 volume with 1 trade. The average volume for the last 60 days is 1,728 and the stock's 52-week low/high is $0.51/$0.10.


Dundee Precious Metals, Inc. (DPMLF)

Penny Stock Tweets, The Street, OTC Markets, MarketWatch, InvestorsHub, YCharts, Capital Cube, Barchart, 4-Traders, and Dividend Investor reported on Dundee Precious Metals, Inc. (DPMLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A global gold mining enterprise, Dundee Precious Metals, Inc. engages in the acquisition, exploration, development, mining and processing of precious metals. The Company acquires, structures and finances, explores, develops and operates its mining and processing assets. Dundee’s strategy includes diversification and vertical integration. The Company has its corporate office in Toronto, Ontario. Dundee Precious Metals lists on the OTC Markets Group’s OTCQB.

The Company’s operating assets include the Chelopech operation situated east of Sofia, Bulgaria. Chelopech produces a copper concentrate containing gold and silver and a pyrite concentrate containing gold.

Operating assets also include the Tsumeb smelter located in Namibia. This is a complex copper concentrate processing facility. In addition, Dundee Precious Metals holds interests in several developing gold and exploration properties in Bulgaria.

These include the Krumovgrad gold project, which commenced construction in Q4 of 2016. The expectation is that it will start production in Q4 of 2018. . Construction at Krumovgrad is proceeding well. Krumovgrad remains on course for first concentrate production in Q4 of 2018 at a lower estimated capital cost. Moreover, operating assets include the Company’s 10.4 percent interest in Sabina Gold & Silver Corp.

Recently, Dundee Precious Metals announced that it completed the earlier announced acquisition of MineRP Holdings Proprietary Limited (MineRP) and combination with its Terrative Digital Solutions Division. Dundee acquired a 78 percent interest in the common shares of MineRP Holdings, Inc. (MineRP Holdings), a new Canadian subsidiary that holds all the shares of MineRP, in exchange for an investment of roughly US$20 million in cash and the transfer of the assets held within Terrative.

Dundee Precious Metals’ Q3 operating highlights include its metals production. The Company produced 48,449 ounces of gold and 9.5 million pounds of copper. This resulted in a further increase in 2017 gold production guidance. It smelted 57,991 tonnes of complex concentrate. Dundee ended Q3 with about $297 million of cash resources.

For Q3 2017, Dundee Precious Metals reported net earnings attributable to common shareholders from continuing operations of $3.1 million ($0.02 per share). This is in comparison to a net loss attributable to common shareholders from continuing operations of $29.8 million ($0.19 per share) for the same period in 2016.

Net earnings attributable to common shareholders from continuing operations in the first nine months of 2017 were $1.6 million ($0.01 per share). This is in comparison to a net loss attributable to common shareholders from continuing operations of $42.5 million ($0.29 per share) for the same period the year prior.

Pertaining to exploration, Dundee Precious Metals continues to center on brownfield exploration at Chelopech and Krumovgrad in Bulgaria and at the advanced Timok Gold Project in Serbia. At the Krumovgrad gold project, earthworks in the process plant area were completed in Q3 of 2017. Additionally, the installation of major foundations began.

Dundee Precious Metals, Inc. (DPMLF), closed Wednesday's trading session at $2.61, up 0.58%, on 13,000 volume with 39 trades. The average volume for the last 60 days is 15,639 and the stock's 52-week low/high is $1.59/$2.70.


FalconStor Software, Inc. (FALC)

StockTwits, Simply Wall St, StreetInsider, Insider Financial, The Street, OTC Markets, Zacks, YCharts, and Business Insider reported on FalconStor Software, Inc. (FALC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, FalconStor Software, Inc. is a market leader in storage software. The Company offers a converged data services software platform that is hardware agnostic. Its open, integrated flagship solution is FreeStor®. This solution lessens vendor lock-in and gives enterprises the freedom to select the applications and hardware components, which make the best sense for their business.

Established in 2000, FalconStor Software has its head office in Austin, Texas. The Company also has offices in Melville, New York, and throughout Europe and the Asia Pacific region.

FalconStor incorporated in Delaware as Network Peripherals, Inc., in 1994. Pursuant to a merger with FalconStor, Inc., in 2001, the previous business of Network Peripherals, Inc. was discontinued. The newly re-named FalconStor Software, Inc. continued the storage software business started in 2000 by FalconStor, Inc.

The Company gives customers the ability to move workloads to the right destination, on-premise or in the cloud. Its FreeStor® offers a true software-defined storage solution with intelligence and built-in analytics. FreeStor® helps lower the cost of storage hardware, modernize existing infrastructure, and helps a business take back control with interoperability, Core-to-Edge insight, and single-pane-of-glass management and monitoring.

FalconStor Software’s corporate mission is to maximize data availability and system uptime to ensure nonstop business productivity. This is while simplifying data management to lessen operational costs.

Recently, FalconStor Software announced financial results for its Q4 and fiscal year ended December 31, 2017. For the three months ended December 31, 2017, the Company delivered Net GAAP (Generally Accepted Accounting Principles) Operating Income of $1.4 million on Revenues of $6.3 million.

For the twelve months ended December 31, 2017, FalconStor delivered GAAP Net Operating Income of $1.0 million versus a Net Operating Loss of $10.3 million for the same period the year prior.

Mr. Todd Brooks, FalconStor Software’s Chief Executive Officer, stated, “Q4 continues the return to profitability first delivered in Q3 2017, and powered the company to an annual profit for 2017, the first since 2008.  This performance further demonstrates the stability our strategic restructuring is creating.”

Last week, FalconStor Software announced the appointment of Mr. Brad Wolfe as Chief Financial Officer (CFO), effective April 9, 2018. In association with the appointment, Pat McClain, the Company’s previous CFO, transitions into a senior advisor role in continued support of FalconStor’s strategic plan execution.

Mr. Wolfe has more than three decades of finance and operations experience. This includes wide-ranging growth-focused leadership within public and private equity, and also M&A (Mergers and Acquisitions), most recently serving as CFO for Asure Software (ASUR).”

FalconStor Software, Inc. (FALC), closed Wednesday's trading session at $0.13, up 8.33%, on 47,276 volume with 14 trades. The average volume for the last 60 days is 84,463 and the stock's 52-week low/high is $0.07/$1.02.


Marfrig Global Foods S.A. (MRRTY)

OTC Markets, Glitch Traders, The Street, MarketWatch, InvestorsHub, YCharts, ResearchPool, Capital Cube, and GuruFocus reported on Marfrig Global Foods S.A. (MRRTY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1986, Marfrig Global Foods S.A. is a multinational company operating in the food and food service industries in Brazil and internationally. Its activities include the production, processing, further processing, sale and distribution of animal proteins and an array of other food products, including breaded products, ready-to-eat meals, fish, frozen vegetables and desserts, among others.

The Company previously went by the name Marfrig Alimentos S.A. It changed its name to Marfrig Global Foods S.A. in January of 2014. OTCQB-listed, Marfrig Global Foods is headquartered in São Paulo, Brazil.

At present, Marfrig Global Foods operates 47 processing units, distribution centers and offices in Brazil and in 11 other countries in South America, North America, Europe, Oceania and Asia. The Company has an annual production capacity of 982,808 metric tons for processed food. It also has an annual slaughtering capacity of 5 million head of cattle, 476.5 million chickens, 8.8 million turkeys and 3.0 million lambs.

Marfrig operates through its Marfrig Beef and Keystone divisions. Marfrig Beef is one of the world's largest beef producers. It is the second largest beef operation in Brazil, the leading beef processer in Uruguay, and also the largest meat importer in Chile.

Keystone is one of the largest global suppliers of industrialized foods to large restaurant and retail chains. Keystone operates 19 production units in the U.S., China, Malaysia, Thailand, South Korea and Australia. Keystone has maintained three research centers developing new products, new processes, as well as new technologies targeted at boosting productivity and efficiency throughout the supply chain.

This week, Marfrig Global Foods announced that on April 9, 2018, it reached an agreement for the acquisition of 51 percent of the membership interests in National Beef Packing Company, LLC. National Beef is the fourth-largest beef processor in the U.S.

Marfrig has agreed to pay US$ 969 million for the equity interest and, upon the conclusion of the transaction, will become the world’s second-largest beef processor, with consolidated sales of R$ 43 billion (US$ 13 billion). Since 2011, National Beef has been controlled by Leucadia National Corporation, which presently holds a 79 percent interest.

National Beef, based in Kansas City, has a slaughtering capacity of 12,000 heads of cattle per day. National Beef has two slaughterhouses located in Dodge City and Liberal, Kansas. The company accounts for roughly 13 percent of total U.S. cattle slaughtering capacity.

Upon the closing of the transaction, Leucadia will transfer control to Marfrig Global Foods and remain a minority shareholder in National Beef, with a 31 percent interest. The US Premium Beef, an association of American producers, will hold 15 percent and other shareholders will hold the remaining 3 percent.

Marfrig Global Foods S.A. (MRRTY), closed Wednesday's trading session at $2.46, down 2.38%, on 56,657 volume with 25 trades. The average volume for the last 60 days is 17,353 and the stock's 52-week low/high is $1.66/$2.52.


Alpine 4 Technologies Ltd. (ALPP)

OTC Markets, Stockhouse, TradingView, InvestorsHub, and MarketWatch reported on Alpine 4 Technologies Ltd. (ALPP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alpine 4 Technologies Ltd. is a technology and manufacturing holding enterprise listed on the OTC Markets Group’s OTCQB. The Company has business-related endeavors in Automotive Technologies, Electronics Manufacturing, Software and Data Technologies. The Company formerly went by the name Alpine 4 Automotive Technologies Ltd. It changed its name to Alpine 4 Technologies Ltd. in June 2015. Formed in 2014, Alpine 4 Technologies is based in Phoenix, Arizona.

The Company’s focus is on how the adaptation of new technologies, even in brick and mortar businesses, can boost innovation. The core of its acquisition strategy is its emphasis on existing smaller middle market operating companies’ with Revenues of $5 to $50 million.

The design of Alpine 4 Technologies is to allow its subsidiaries room to develop their own identities and synergistically prosper from inter-company resources and collaboration. Alpine 4 will own controlling interest in every subsidiary. Moreover, Alpine 4 will have direct control over planning and management.

Regarding the Company’s subsidiaries and product groups, these include ALTIA; Quality Circuit Assembly; and Venture West Energy Services. ALTIA is an automotive products company

Alpine 4’s Quality Circuit Assembly subsidiary provides electronic contract manufacturing solutions delivered to its customers via strategic business partnerships. Venture West Energy Services centers on supporting the oil and gas industry in Texas, Oklahoma, and Arkansas.

In January 2018, Alpine 4 Technologies announced that it started two pilots of SPECTRUMebos, a blockchain Enterprise Business Operating System, in its subsidiaries Quality Circuit Assembly and ALTIA, LLC.

SPECTRUMebos is an Enterprise Business Operating System (EBOS) developed by Alpine 4 Technologies. It combines the key technology software mechanisms of Accounting and Financial Reporting of an Enterprise Resource Planning System (ERP), a Document Management System (DMS), a Business Intelligence (BI) platform and a Customer Resource Management (CRM) hub all tethered to a management reporting and collaboration toolset.

This week, Alpine 4 Technologies announced that it completed its acquisition of American Precision Fabricators, Inc. (APF).  The acquisition adds to Alpine 4 Technologies’ technology manufacturing sector play that started in 2016 with the Company’s purchase of Quality Circuit Assembly. In addition, it is the fourth acquisition that Alpine 4 has made in two years.

Established in 1996, APF is an Arkansas headquartered corporation.  For more than 20 years, APF has been an industry leader for customers in the OEM (original equipment manufacturing) markets, fabricating and manufacturing components and products for numerous Fortune 1000 customers.

Alpine 4 Technologies Ltd. (ALPP), closed Wednesday's trading session at $0.10, even for the day, on 8,875 volume with 3 trades. The average volume for the last 60 days is 22,552 and the stock's 52-week low/high is $0.09/$4.00.


Dais Analytic Corp. (DLYT)

HotOTC, SmallCapVoice, CoolPennyStocks, MadPennyStocks, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, BullRally, PennyInvest, PennyStockVille, and Greenbackers reported earlier on Dais Analytic Corp. (DLYT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. A commercial nanotechnology materials enterprise, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is headquartered in Odessa, Florida.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product).

In addition, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle. Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water.

The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component.

NanoClear™ is a leading-edege water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a critical application in purifying contaminated water having high salt content, low pH, or where the requirement for Total Dissolved Solid (TDS) in the product water is 10 or less.

Furthermore uses include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and also 'smart grid' configurations.

This past summer, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China, to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the increasing Chinese heating, ventilation and air conditioning (HVAC) market.

Energy Recovery Ventilators are used in association with HVAC equipment to save capital and operating costs. This is while improving the quality of life for the building's occupants.

High effectiveness ERVs, such as ConsERV™ or Menred Group's new line of ERVs to be built utilizing Dais Analytic's Aqualyte nanomaterial, enable architects and engineers to design buildings with considerable volumes of filtered, preconditioned supply air.

Mr. Brian Johnson Dais Analytic’s Chief Technology Officer, said in July 2017, "Dais' ConsERV™ has long been a leader in this field as established by our Air-Conditioning, Heating and Refrigeration Institute (AHRI) certified performance -- along with other similar ratings from 3rd party rating company's worldwide. Our Aqualyte™ nanomaterial, now in its 4th generation, drives this performance and we are excited about working with Menred to bring a new series of ERVs with Aqualyte to the growing Chinese ERV market."

Dais Analytic Corp. (DLYT), closed Wednesday's trading session at $0.0201, down 8.64%, on 45,101 volume with 7 trades. The average volume for the last 60 days is 69,873 and the stock's 52-week low/high is $0.01/$0.09.


Midwest Energy Emissions Corp. (MEEC)

MissionIR, SeriousTraders, Greenbackers, Marketbeat, Wall Street Resources, TopPennyStockMovers, NBT Equities Research, and PennyStocks24 reported on Midwest Energy Emissions Corp. (MEEC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Midwest Energy Emissions Corp. is a developing leader in mercury emissions control technology for the international coal-power industry. The Company develops and utilizes patented and proprietary technologies to remove mercury from coal-power plant emissions. Midwest Energy Emissions centers on the delivery of mercury capture technologies to power plants and other industrial coal-burning units in North America, Europe, and Asia. OTCQB-listed, the Company is headquartered in Lewis Center, Ohio.

Midwest Energy Emissions employs patented technology, which has been shown to achieve mercury removal levels compliant with the U.S. Environmental Protection Agency's (EPA) Mercury and Air Toxic Standards (MATS) rule, at a substantially lower cost and with less operational impact than methods currently used. This is while preserving the ability for customers to recycle and sell fly-ash for beneficial use.

Its proprietary SEA™ (Sorbent Enhancement Additive) technology delivers a flexible, tunable solution. It allows the worldwide coal-power industry to easily comply with new, highly restrictive regulations on mercury air emissions. The SEA™ approach to mercury capture is precisely tailored for each application to complement a customer’s fuel type and boiler configuration for best results.

Midwest Energy Emissions has acquired all patent rights for its Sorbent Enhancement Additive (SEATM) mercury emissions control technology from the Energy & Environmental Research Center Foundation (EERCF of Grand Forks, North Dakota). The Company acquired the rights for $2.5 million and 925,000 shares of common stock in Midwest Energy Emissions. EERCF is an organization that works to provide inventive solutions to the globe’s energy and environmental challenges.

Midwest Energy Emissions is adding a new product to its proven, cost-effective mercury capture program, which will reduce mercury emissions by preventing scrubber reemission events. The design of the product is specifically for coal-fired power utilities with wet scrubbers to help remove mercury and other metals from the scrubber.

This past February, Midwest Energy Emissions announced that it was recently recognized by Vistra Energy at its Nexus Awards Recognition Reception. Midwest Energy Emissions received the Nexus Small Business Award, presented to Small Business Enterprises that provide excellent service, have demonstrated a strong and positive commitment to their community, and support the use of a diverse workforce and supply chain including other small businesses.

Midwest Energy Emissions will host a conference call on Tuesday, April 17, 2018 at 5:00 p.m. Eastern time to discuss its financial results for Q4 and full year ended December 31, 2017.

Midwest Energy Emissions Corp. (MEEC), closed Wednesday's trading session at $0.25, down 1.92%, on 176,850 volume with 21 trades. The average volume for the last 60 days is 28,318 and the stock's 52-week low/high is $0.20/$1.28.


Yew Bio-Pharm Group, Inc. (YEWB)

Awesome Penny Stocks, OTC Markets, Barchart, Greenbackers, Zacks, Marketbeat, Insider Monkey, Stockhouse, TradingView, 4-Traders, Amigobulls, Stockrow, Simply Wall St, and YCharts reported on Yew Bio-Pharm Group, Inc. (YEWB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Yew Bio-Pharm Group, Inc., via its operating entity, Harbin Yew Science and Technology Development Co., Ltd. (HDS), is a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM), handicraft products made from yew timber, and yew candle and soap made with yew essence oil in China. Formed in 1996, Yew Bio-Pharm has its corporate headquarters in Xiangfang District, Harbin City, Heilongjiang Province, China.

Yew Bio-Pharm grows Japanese yew trees (also known in China as Northeast yew trees), taxus cuspidata, on mountain hillsides close to Harbin. It cultivates them in four nurseries it operates near Harbin.

Raw material from the species of yew tree that Yew Bio-Pharm grows contains taxol. In addition, TCM containing yew raw materials has received approval as a traditional Chinese medicine (TCM) in China for the secondary treatment of certain cancers.

The Company utilizes a patented, accelerated growth technology to speed up the growth and maturity and commercialization of yew trees. Furthermore, Yew Bio-Pharm has created a division to focus on organic foods and dietary supplements. Its objective is to develop new business opportunities in related industries.

Additionally, Yew Bio-Pharm operates production facilities to manufacture yew handicrafts. Its patented Asexual Reproduction Method expedites the commercial viability of a yew tree. Consequently, a yew tree can be used for commercialization beginning in approximately three years, in comparison to greater than 50 years for naturally grown yew trees.

Through this method, Yew Bio-Pharm can more than replenish the number of yew trees it cultivates and puts into production. The patented Asexual Reproduction Method was developed by Yew Bio-Pharm’s Founder and President, Mr. Zhiguo Wang. The Patent is valid through September 29, 2030.

Last week, Yew Bio-Pharm Group reported financial results for the three- and twelve-months ended December 31, 2017. Total Revenue for Q4 of 2017 decreased 54.2 percent to $5.5 million from $12.0 million a year prior. Net Income in Q4 of 2016 was a loss of $7.8 million, or a loss of $0.14 per diluted share, versus a loss of $1.4 million in the year-ago quarter, or a loss of $0.03 per diluted share.

Total Revenues for the 2017 fiscal year were $40.5 million. This is a 21.0 percent decrease from $51.3 million a year prior. Net Income for 2017 increased to $3.2 million, or 0.06 per diluted share, from $2.0 million, or $0.04 per diluted share for 2016.

Mr. Zhguo Wang, Chairman and Chief Executive Officer of Yew Bio-Pharm Group, said, "Our TCM raw materials and Others segment sales contributed most of our revenues for the year 2017. We developed a series of yew product derivatives such as yew oil candle, yew essential oil soap, face serum and moisturizer cosmetics which contain yew essential oil, functional pillow, complex Taxus Cuspidate extract and composite northeast yew extract since from year 2015, and these products have been accepted by more and more customers of the U.S. and Chinese market."

Yew Bio-Pharm Group, Inc. (YEWB), closed Wednesday's trading session at $0.395, down 1.25%, on 14,000 volume with 1 trade. The average volume for the last 60 days is 11,038 and the stock's 52-week low/high is $0.1789/$0.4699.


The QualityStocks Company Corner

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced today it has received another new Notice of Allowance from the United States Patent and Trademark Office ("USPTO") providing claims that protect processes for making specific compositions of matter for enhanced cannabinoid delivery utilizing its DehydraTECH™ technology. Also today, NetworkNewsWire released a report on the company detailing how DehydraTECH™ is a unique enabling technology from Lexaria Bioscience that increases the absorption rate of edible ingestion, delivering five to 10 times more of active ingredients than traditional edibles.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Today's trading session at $0.93, up 2.20%, on 140,134 volume with 96 trades. The average volume for the last 60 days is 250,959 and the stock's 52-week low/high is $0.27/$2.54.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) announced on April 5, 2018, that its Unified Payments subsidiary has launched a same-day funding service, called Fast Pass Funding, through its proprietary Netevia platform (

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Today's trading session at $7.39, up 3.07%, on 314,945 volume with 1,185 trades. The average volume for the last 60 days is 823,379 and the stock's 52-week low/high is $2.556/$33.51.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST) is pleased to announce that Mr. Jad Nammour has joined ETST as the Company’s new Chief of Pharmacy.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Tuesday's trading session at $0.67, off by 4.29%, on 8,607 volume with 13 trades. The average volume for the last 60 days is 31,931 and the stock's 52-week low/high is $0.324/$1.75.

Recent News


AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF).

Artificial intelligence (“AI”) company AnalytixInsight (TSX.V: ALY) (OTCQB: ATIXF) provides investors with insightful analysis amid shifting market trends. To view the full article, visit:

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company’s flagship product – – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube’s freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy’s largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo’s 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo’s established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners.

AnalytixInsight Inc. (ATIXF), closed Wednesday's trading session at $0.3351, even for the day. The average volume for the last 60 days is 8,215 and the stock's 52-week low/high is $0.15/$0.6898.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt (TSX.V: FCC) (OTCQB: FTSSF) this morning announced the release of its 2018 corporate video on the company's website and social media sites. To view the video, visit To view the full press release, visit:

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed Today's trading session at $0.71, off by 1.39%, on 84,511 volume with 93 trades. The average volume for the last 60 days is 214,158 and the stock's 52-week low/high is $0.3148/$1.3041.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) remains focused on branding, building a chain of its own Choom retail dispensaries, positioning its premium brand and acquiring production assets. To view the full article, visit:

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed Today's trading session at $0.64, off by 5.17%, on 62,654 volume with 67 trades. The average volume for the last 60 days is 114,255 and the stock's 52-week low/high is $0.125/$0.8612.

Recent News


Pivot Pharmaceuticals Inc. (PVOTF)

The QualityStocks Daily Newsletter would like to spotlight Pivot Pharmaceuticals Inc. (PVOTF).

On April 4, 2018, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) published an update on the advancements of its industry-leading cannabis product pipeline (

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.

Research into the bioavailability of cannabinoid-based therapeutics shows that rates of absorption vary greatly between smoking cannabis to an orally-consumed product, with a difference noted even between individuals. Cannabinoids are degraded in the stomach and smoking may not appeal to patients for health or lifestyle reasons. Topical delivery, while a better alternative, has suffered from weak formulation issues. Transdermal cannabinoid delivery, on the other hand, could provide a better alternative route since it reduces side effects and bypasses other absorption issues. In addition, transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects.

Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in FDA and EMA approved human clinical trials, which have shown the delivery system enhances the bioavailability of many drugs and improves clinical outcomes. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids (CBD) that can receive a Health Canada Natural Health Product (NHP) designation. This marketing method ensures a shorter development cycle and faster revenue generation opportunities.

Pivot Pharmaceuticals Inc., which has positioned itself as a growing and crucial vertical in the cannabis industry, represents a compelling opportunity in the biotechnology field. The company’s plans include working with Licensed Producers (LP) and Licensed Dealers (LD) to bring newer therapies to patients. The company has also applied to list on the Canadian Stock Exchange (CSE).

The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of states and countries gaining approval for using cannabis in therapeutic applications is expected to continue driving the market forward.

Pivot Pharmaceuticals has assembled a highly experienced management team, bringing together a wealth of clinical, commercial, product development and financial experience. Among the many healthcare targets in Pivot’s pipeline are cancer supportive care, pain and inflammation, women’s sexual dysfunction, dermatology and eye disease.

Pivot Pharmaceuticals Inc. (PVOTF), closed Today's trading session at $0.61259, off by 9.91%, on 94,283 volume with 93 trades. The average volume for the last 60 days is 80,046 and the stock's 52-week low/high is $0.047/$2.46.

Recent News


Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ).

Epazz Inc. (OTC: EPAZ), a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that the company has acquired the Play Store app Tap Tap Bitcoin Clicker, which has been downloaded more than 24,000 times.

Epazz, Inc. (EPAZ) is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company’s strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

“We are starting 2018 with ZenaPay on both major mobile apps’ platforms,” said Shaun Passley, PhD, CEO and founder of Epazz. “We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company.”

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz’s unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

“Blockchain-based technology is the future of the Internet,” Passley said. “Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come.

Epazz, Inc. (EPAZ), closed Today's trading session at $0.08, off by 13.89%, on 364,510 volume with 61 trades. The average volume for the last 60 days is 277,154 and the stock's 52-week low/high is $0.0045/$0.52.

Recent News


AV1 Group, Inc. (AVOP)

The QualityStocks Daily Newsletter would like to spotlight AV1 Group, Inc. (AVOP).

AV1 Group, Inc. (AVOP) is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies, grow houses and cultivation, and e-commerce businesses positioned for exponential growth. After identifying businesses displaying revolutionary concepts able to develop a substantial footprint in high-growth markets, the business model followed calls for incubating and supporting the best opportunities.

The company seeks to discover inspired entrepreneurs with innovative ideas that are poised for significant revenue generation. Management expertise can be seen in the development of embryonic-stage subsidiaries as the company brings a spectrum of backgrounds to the table with a significant resource of knowledge and experience to every venture. AV1 Group explores every opportunity to help each sector exceed its revenue goals while building close, active working relationships as it prepares each respective division to be a robust competitor within the various chosen markets.

AV1 Group companies include:

  • – Intelligent lighting solutions and wireless access for many different applications.
  • – Over 800 vaping products; bitcoin payments accepted.
  • – Revolutionary dual jet dental water jet integrates hemp oil infusing.
  • – Comprehensive, energy-efficient lighting solutions.
  • – Wholly owned subsidiary building strategic relationships in the LED sector to provide solutions for grow houses and cultivation centers.
  • MJIQ – First, comprehensive, enterprise-grade integrated software suite being developed for the legal cannabis industry.
  • – Engaging online destination for all hemp and cannabis related products and services.
  • – Puts consumers and small businesses in contact with legal services and service providers.
  • – Under development website will serve cannabis dispensaries, laboratories and industry affiliates.

AV1 Group’s business model delivers an advantage with internally-created projects that are poised for revenue generation and a cross-company revenue platform that enables the company to incubate and foster growth in early-stage subsidiaries under one umbrella.

AV1 Group, Inc. (AVOP), closed Today's trading session at $0.0199, up 13.07%, on 45,706 volume with 6 trades. The average volume for the last 60 days is 47,998 and the stock's 52-week low/high is $0.014/$0.28.

Recent News


Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P)

The QualityStocks Daily Newsletter would like to spotlight Liberty Leaf Holdings Ltd. (LXRP).

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (OTCQB: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this dynamic and fast-growing sector. Liberty Leaf provides funding, management, HR resources and marketing expertise to help companies thrive and accelerate growth.

Liberty Leaf’s leading investments to date include:

  • North Road Ventures – An emerging end-to-end distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road has updated its application for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to be distribution/sales-focused, making the company unique in the crowded field of other cultivation-based applicants. This forward-thinking initiative will help fulfill the anticipated increase in Canada’s recreational cannabis space once legalization takes effect in mid-2018. The submission includes a boost in product-vault capacity that will result in a five-fold increase in products available for distribution. Cannabidiol (CBD)-oil products are expected to account for 50 percent or more of projected sales.
  • Just Kush Enterprises – Liberty Leaf holds a 60 percent interest in Just Kush, a cultivator of premium, proprietary cannabis strains selected for different levels of CBDs and THCs. Just Kush’s cultivation facility is located near Oliver, British Columbia, and it currently controls a facility which holds a Medical Marihuana Access Regulations (MMAR) license. The company is also a late-stage applicant for an ACMPR license (Access to Cannabis for Medical Purposes Regulations), which will enable Just Kush to produce cannabis for the medicinal and recreational market.

Liberty Leaf is also an active partner with the following companies:

  • ESEV R&D – A privately owned, medical marijuana research and development company based in New York with clinical laboratories located in Israel. ESEV R&D, in collaboration with a leading clinical research organization in Israel, has launched a one-of-a-kind service for North American medical cannabis companies to organize and oversee clinical trials seeking to demonstrate the efficacy of medical cannabis products for specific medical conditions. Liberty Leaf has a three-year collaborative agreement with ESEV. Under that agreement, ESEV is researching the efficacy of CBDs in pets, with the 1st formulation trial targeting canine osteoarthritis, a medical condition that includes: hip dysplasia; elbow dysplasia; and hind-knee, also known as stifle, degenerative joint disease (DJD).
  • Blox Labs Inc. – A boutique technology development company focused on creating best-in-class software solutions driven by emerging trends in blockchain, smart contracts and decentralized application technologies. Liberty Leaf and Blox Labs are developing “cannaBLOX,” a blockchain-based smart contract supply chain management platform for the legalized cannabis industry. The cannaBLOX blockchain software will aim to ease and obliterate logistical bottlenecks, ensure product safety and quality of supply, minimize fraud and potential criminal activity, and assist with taxation and regulatory compliance across various levels of government within the legalized cannabis marketplace. To date, preliminary framework and analysis required for a cannaBLOX Whitepaper has been completed and a development team that specializes in blockchain and decentralized application technologies, including omni-language development in Ethereum and NEO, is now working on the project.

The company’s management team is led by President and Director William Rascan who has 25-plus years in the investment brokerage industry, most recently as a partner, senior investment advisor with Northern Securities. Rascan’s business experience ranges from active international trading clients to raising capital for junior mining companies on the TSX Venture Exchange.

Rascan is joined by CFO Jamie Robinson, a chartered accountant who specializes in accounting, auditing, and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Robinson worked at Deloitte as a manager focused on publicly listed and private company audits, business review, performance enhancement engagements and restructuring proceedings.

Steven Feldman, who has more than 25 years of experience in the capital markets and was part of the original management team of SouthGobi Resources; and Doug Macdonell, a retired RCMP officer and recognized expert in the field of cannabis and cultivation, serve as company directors. Dr. Robert Jackman, who has worked closely with multiple clients in the medical cannabis and Natural and Non-prescription Health Products (NNHP) industries in North America, was recently appointed as scientific project manager/fulfillment.

Liberty Leaf’s advisory board includes international lawyer, writer and speaker Robert W.E. Laurie; Barinder Rasode, who currently serves as CEO of the National Institute for Cannabis Health & Education (NICHE); and Dr. Mary C. Fitzpatrick, B.S., D.V.M., whose primary focus is on helping companion animals live pain free in their senior years.

Liberty Leaf Holdings Ltd. (LIBFF), closed Today's trading session at $0.277, off by 0.75%, on 3,195 volume with 7 trades. The average volume for the last 60 days is 80,930 and the stock's 52-week low/high is $0.0091/$0.8074.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.